A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Bartlett, Nancy L., Herrera, Alex F., Domingo-Domenech, Eva, Mehta, Amitkumar, Forero-Torres, Andres, Garcia-Sanz, Ramon, Armand, Philippe, Devata, Sumana, Rodriguez Izquierdo, Antonia, Lossos, IzidorJournal:
Blood
DOI:
10.1182/blood.2019004701
Date:
July, 2020
File:
PDF, 1.41 MB
2020